• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
LBT
Click for more information
6.25% 1.7¢

LBT INNOVATIONS LIMITED - News & Media

Market Cap $29.73M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

LBT Innovations is a ground-breaking designer of advanced technology solutions for the... LBT Innovations is a ground-breaking designer of advanced technology solutions for the medical industry. We specialise in combining artificial intelligence, image analysis and software engineering to improve healthcare delivery. Our product, APAS® Independence, is a global first solution for automated reading of microbiology culture plates.More

Articles & Videos

LBT inks $4.1M deal with AstraZeneca for AI platform technology

LBT Innovations Ltd has seen its share price rise more than 33% on news of the deal with the multinational pharmaceutical company.

07 Aug 2024 12:16 (AEST)

LBT Innovations (ASX:LBT) partners with AstraZeneca for APAS Pharma development

LBT Innovations (ASX:LBT) has been engaged by AstraZeneca to undertake a full product development project for its APAS Pharma product.

09 Jan 2023 14:12 (AEDT)



(20min delay)
Last
1.7¢ 		Change
0.001(6.25%) 		Mkt cap ! $29.73M
Open High Low Value Volume
1.5¢ 1.8¢ 1.5¢ $45.53K 2.767M

Buyers (Bids)

No. Vol. Price($)
1 246138 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 619099 3
View Market Depth
Last trade - 15.59pm 01/10/2024 (20 minute delay) ?
Last
1.7¢ 		  Change
0.001 ( 13.3 %)
Open High Low Volume
1.6¢ 1.7¢ 1.6¢ 627407
Last updated 15.38pm 01/10/2024 ?
LBT (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.